SCHEMBL15528933

SCHEMBL15528933

CCOc1ccccc1C(=O)Nc1cccc(C(=O)OC)c1N

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.64
GAA P10253 3/20 0.64
MAPK1 P28482 3/20 0.64
L3MBTL1 Q9Y468 2/20 0.62
LMNA P02545 2/20 0.62
HTT P42858 1/20 0.62
ALDH1A1 P00352 1/20 0.60
MEN1 O00255 3/20 0.59
KMT2A Q03164 3/20 0.59
TSHR P16473 3/20 0.58
HSD17B10 Q99714 2/20 0.58
KCNK3 O14649 1/20 0.57
KCNK9 Q9NPC2 1/20 0.57
RXFP1 Q9HBX9 5/20 0.57
KDM4E B2RXH2 1/20 0.57
HPGD P15428 1/20 0.57
ATM Q13315 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
TP53 P04637 2/20 0.57
KCNMA1 Q12791 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15528687 0.89 GAA (0.66) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL15528654 0.88 MAPT (0.74) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL5619629 0.87 SGMS2 (0.60) MAPTGAAMAPK1L3MBTL1ALDH1A1
SCHEMBL24009066 0.82 ALDH1A1 (0.50) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL30288409 0.82 ALDH1A1 (0.50) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL18255503 0.81 RAB9A (0.64) MAPTGAAMAPK1LMNAALDH1A1
SCHEMBL15323115 0.81 GAA (0.78) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL1989129 0.79 HCRTR1 (0.65) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL30553984 0.79 HCRTR1 (0.65) MAPTGAAMAPK1L3MBTL1LMNA
SCHEMBL11794695 0.79 KCNK3 (0.66) MAPTGAAMAPK1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2844345-B1 MODULATORS OF THE RELAXIN RECEPTOR 1 US HEALTH (US) 2022-08-03 EP disclosed
US-10125112-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-11-13 US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 US disclosed
EP-2844345-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 The United States of America, as Represented by The Secretary, Department of Health and Human Services (US) 2015-03-11 EP disclosed
WO-2013165606-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-11-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 MAPT 4541/4885GAA 3991/4885MAPK1 1480/4885
US-10125112-B2 Modulators of the relaxin receptor 1 RXFP1, RXFP2, RXFP3 MAPT 4541/4885GAA 3991/4885MAPK1 1480/4885
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 MAPT 4541/4885GAA 3991/4885MAPK1 1480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.